Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Rash macular? 159 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Rash macular have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.2% of all adverse event reports for AMLODIPINE.

159
Reports of Rash macular with AMLODIPINE
0.2%
of all AMLODIPINE reports
1
Deaths
55
Hospitalizations

How Dangerous Is Rash macular From AMLODIPINE?

Of the 159 reports, 1 (0.6%) resulted in death, 55 (34.6%) required hospitalization, and 7 (4.4%) were considered life-threatening.

Is Rash macular Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 159 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Rash macular?

ADAPALENE (3,987) DUPILUMAB (3,771) AVOBENZONE\OCTISALATE\OCTOCRYLENE (3,092) ADALIMUMAB (1,407) LENALIDOMIDE (632) ETANERCEPT (627) SECUKINUMAB (552) IBRUTINIB (375) AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (371) APIXABAN (279)

Which AMLODIPINE Alternatives Have Lower Rash macular Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Rash macular Reports All Drugs Causing Rash macular AMLODIPINE Demographics